Advanced in Hepatic Venoocclusive Disease with Immunodeficiency

Heiwa Kanamori

Yokohama, JP 
Advanced in Hepatic Venoocclusive Disease with Immunodeficiency
Yokohama, JP 
OverviewLocationsClinical Research

Overview

Heiwa Kanamori practices in Yokohama, Japan. Kanamori is rated as an Advanced expert by MediFind in the treatment of Hepatic Venoocclusive Disease with Immunodeficiency. Their top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Their clinical research consists of co-authoring 178 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hepatic Venoocclusive Disease with Immunodeficiency.

Locations

Yokohama, Japan
Other Locations
Kanagawa, Japan
Tsukuba, 3058518, Japan
Chuo, 2525210, Japan
Tokyo, Japan
Kurihara, Japan
Sendai, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
Enrollment Status: Completed
Publish Date: March 03, 2020
Intervention Type: Drug
Study Phase: Phase 1

178 Total Publications

Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation.
Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation.
Journal: Cytotherapy
Published: December 05, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kanamori's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile